JNE Partners LLP - Q2 2022 holdings

$153 Million is the total value of JNE Partners LLP's 14 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 66.7% .

 Value Shares↓ Weighting
BABA SellALIBABA GROUP HLDG LTDsponsored ads$9,322,000
-57.2%
82,000
-59.0%
6.09%
-40.9%
CP ExitCANADIAN PAC RY LTD$0-306,300
-100.0%
-11.97%
CMCSA ExitCOMCAST CORP NEWcl a$0-561,902
-100.0%
-12.45%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RES INC16Q3 202334.9%
AMERCO11Q3 202240.0%
ELLIOTT OPPORTUNITY II CORP9Q2 202319.8%
COMCAST CORP NEW8Q1 202223.5%
ORION BIOTECH OPPORTUNTES CO8Q1 202311.1%
MSD ACQUISITION CORP8Q4 202211.1%
LIBERTY MEDIA CORP DEL8Q2 202313.9%
ROCKET INTERNET GRWT OPRT CO8Q4 20223.2%
KKR ACQUISITION HOLDING I CO7Q3 20221.7%
MICRON TECHNOLOGY INC5Q3 202356.9%

View JNE Partners LLP's complete holdings history.

Latest significant ownerships (13-D/G)
JNE Partners LLP Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Prevail Therapeutics Inc.January 29, 2021? ?

View JNE Partners LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-15

View JNE Partners LLP's complete filings history.

Compare quarters

Export JNE Partners LLP's holdings